Skip to main content
. 2017 Nov 26;40(2):166–181. doi: 10.1016/j.bjhh.2017.08.008

Table 2.

Main risk or protective factors for overt ischemic stroke in sickle cell disease.

Risk or protective factor Effect on risk of stroke References
Validated predictive factor
 Doppler TAMMV ≥200 cm/s in MCA/ICA Increases risk 12, 13



Laboratory factors
 High steady state reticulocyte count Increases risk 7, 13, 79, 82, 83, 109, 110, 111, 138, 148
 Low total hemoglobin Increases risk 8, 21, 72, 76, 79, 80, 99, 109, 110, 148
 High LDH Increases risk 7, 77, 79, 99, 108
 High WBC Increases risk 13, 44, 82, 135
 G6PD deficiency Very controversial 7, 77, 101, 109, 112, 120, 122, 147, 151



Genetic factors
 Coinheritance of alpha-thalassemia Protective 7, 8, 51, 75, 76, 77, 79, 80, 81, 98, 101, 102, 138, 151
 Other genetic factors Controversial or preliminary 78, 82, 89, 90, 91, 96, 97 and others (see references)



Clinical factors
 Silent infarcts Increases risk 122, 127
 Prior transient ischemic attack Increases risk 8, 127
 Doppler TAMMV ≥170 cm/s in ACA Increases risk 146
 Low nocturnal or daytime SpO2 Increases risk 21, 126, 129, 130, 131
 Relative high systolic blood pressure Increases risk 8, 137, 140
 Recurrent acute chest syndrome Increases risk 8, 82

TAMMV: time averaged maximum mean velocity; MCA: middle cerebral artery; ICA: internal carotid artery; LDH: lactate dehydrogenase; WBC: white blood cell; G6PD: glucose-6-phosphate dehydrogenase; ACA: anterior cerebral artery; SpO2: peripheral capillary oxygen saturation.